50
Participants
Start Date
February 23, 2012
Primary Completion Date
November 30, 2015
Study Completion Date
November 30, 2016
Buprenorphine/naloxone
2/0.5, 8/2 sublingual tabs; dosage based on medical assessment; medications taken once per day for 12 months duration.
Placebo Oral Tablet
2/0.5, 8/2 sublingual tabs; dosage based on medical assessment; medications taken once per day for 12 months duration.
Howard University, Washington D.C.
George Mason University
OTHER
Howard University
OTHER
National Institute on Drug Abuse (NIDA)
NIH
Yale University
OTHER